UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

 

For the Month of: November 2019

 

Commission File Number: 001-37847

 

MOTIF BIO PLC

(Exact name of registrant as specified in its charter)

 

125 Park Avenue

25th Floor

New York, New York 10017

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.  

 

Form 20-F ☒ Form 40-F ☐  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___  

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___      

 

 

 

 

 

MOTIF BIO PLC

FORM 6-K

 

 

American Depositary Shares (“ADS”) Program and Warrant Agent Agreement

 

On November 27, 2019, Motif Bio plc (the “Company”) issued a regulatory news service announcement stating that further to the announcement yesterday of the Company’s intention to voluntarily delist its American Depository Shares (ADSs), it has given notice on November 26, 2019 to The Bank of New York Mellon to terminate its American Depositary Shares Program and Warrant Agent Agreement. A copy of the regulatory news service announcement is attached herein as Exhibit 99.1.

 

The information contained in this report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-222614 and 333-222042), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

Exhibits

 

Exhibit 99.1 Regulatory News Service announcement issued on November 27, 2019, entitled “American Depositary Shares (“ADS”) Program and Warrant Agent Agreement.”

 

 

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MOTIF BIO PLC
     
  By: /s/ Graham Lumsden
  Name: Graham Lumsden
  Title: Chief Executive Officer

 

Date: November 27, 2019

 

 

 

Motif Bio (NASDAQ:MTFB)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Motif Bio Charts.
Motif Bio (NASDAQ:MTFB)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Motif Bio Charts.